{
  "question": "患者信息：女24岁重庆万州区月经干净后一两天，洗澡发现能挤的出来，以前挤过好象没有是不是正常的，担心曾经治疗情况及是否有过敏、遗传病史：否",
  "retrieved_context": "{\n  \"retrieved_context\": [\n    {\n      \"content\": \"Oncogenicactivation of RAS/MAPK is associated with a significant reduction in tumor-infiltrating lymphocytes (TILs) and lower survivalin TNBC patients, while concomitant MEK inhibition and antiPD1/PD-L1 immunotherapy augmented anti-tumor immunity inpreclinical TNBC models (Loi et al., 2016)In addition to theERK pathway, MAP3K1 can regulate MAPK-JNK signalingthrough phosphorylation of substrates such as MAP2K4Relatively frequent somatic mutations occur in MAP2K4 andMAP3K1 in luminal cancers (12% in total), often coincidentwith PIK3CA mutationsWhile JNK pathway activation is predictive of chemotherapy sensitivity in TNBC, recent evidence suggests JNK signaling fosters an immunosuppressive TME to drive tumor progression, implicating JNK-targeted immunotherapy asa potential treatment strategy for TNBC (Semba et al., 2022).Cyclin D1-CDK4/6-RB axisThe cyclin D1-CDK4/6-RB axis is the pivotal regulator of theG1-S transition of the cell cycle\",\n      \"title\": \"Deciphering breast cancer_ from biology to the clinic.pdf\"\n    },\n    {\n      \"content\": \"n engl j med 375;8 nejm.org August 25, 2016 71970-Gene Signature in Early Breast Cancerclinical and genomic results were advised not to receive adjuvant chemotherapy, whereas patients who were categorized as having high-risk disease by both tests were advised to receive chemotherapy.Patients with discordant results (i.e., either high clinical risk and low genomic risk or low clinical risk and high genomic risk) were randomly assigned to the chemotherapy group or the no-chemotherapy group on the basis of either the clinical result or the genomic resultThe treatment randomization used a minimization technique that was stratified according to institution, risk group, hormone-receptor status (ER-positive or progesterone [PR]-positive vsER-negative and PR-negative), nodal involvement (yes or no), age (<50 years vs≥50 years), HER2 status (HER2-positive vsHER2-negative vsunknown), axillary treatment (sentinel node only vsdissection), and type of surgery (mastectomy vs\",\n      \"title\": \"CSCO BC指南参考文献29.pdf\"\n    },\n    {\n      \"content\": \"Many other reviews reached similar conclusions, reporting positive moderate effect sizes of mind-body interventions on anxiety and distress in cancer.45, 98Risk/Benefit assessment of meditation interventions: Meditation therapies pose very little risk to participants in this type of interventionFew adverse events have been reported in any trials, but there has been recent interest within the meditation research community in exploring adverse reactions to intensive meditation practice, particularly in vulnerable individuals.99, 100 Typically, potential participants are screened through individual orientation interviews prior to joining meditation group programs, and participants who have serious mental health issues are often re-directed to individual counseling or psychiatric intervention prior to or concomitant with mind-body intervention participation\",\n      \"title\": \"Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.pdf\"\n    },\n    {\n      \"content\": \"If more than 50% of the constituent items on theQLQ-C30 and QLQ-BR23 scales were completed, a prorated score was computed.17 For scales with less than 50%of the items completed, the scale was considered missing.Mean change of the linear transformed scores frombaseline—and SEs—were computed for each assessmenttimepoint.RESULTSFrom June 2014 to June 2015, 444 patients were randomlyassigned (T-DM1+P, n = 223; TCH+P, n = 221; Fig 1 andAppendix Table A1, online only), and all but two patients inthe TCH+P arm received one or more dose of study medication.12 Baseline characteristics were balanced between arms (Appendix Table A2, online only)Hormone receptor–positive disease was present in 62.2% of patients,and 83.1% had clinical stage IIA to IIIA disease, 66.4%were white, and 25.2% were Asian\",\n      \"title\": \"CSCO BC指南参考文献11.pdf\"\n    },\n    {\n      \"content\": \"Both groups also received concurrent intravenous trastuzumab, with an initial loading dose of 8 mg/kg and a maintenance dose of 6 mg/kg on day 1, as well as intravenous pertuzumab with a loading dose of 840 mg and a maintenance dose of 420 mg on day 1This report is the final analysis of the primary endpoint, pathological complete response (ypT0/is ypN0), analysed in all patients who started treatment (modified intention to treat)The trial is registered with ClinicalTrials.gov, NCT04547907, and follow-up of the adjuvant phase is ongoing.Findings Between Sept 20, 2020, and March 1, 2023, 789 patients were screened for eligibility, 689 of whom were randomly assigned (343 to the nab-paclitaxel group and 346 to the docetaxel plus carboplatin group)All 689 patients were Asian women669 patients received at least one dose of the study treatment and were included in the full analysis set (332 in the nab-paclitaxel group and 337 in the docetaxel plus carboplatin group)\",\n      \"title\": \"CSCO BC指南参考文献13.pdf\"\n    },\n    {\n      \"content\": \"Recently, a new subclass of malignant cells within tumors called the cancer stem cells (CSCs) are observed and associated with tumor initiation, escape and recurrenceThis small population of cells, which may develop from stem cells or progenitor cells in normal tissues, have self-renewal abilities and are resistant to conventional therapies such as chemotherapy and radiotherapy [13-15]Breast cancer stem cells (bCSCs) were first identified by Ai Hajj and even as few as 100 bCSCs could form new tumors in the immunocompromised mice [16]bCSCs are more likely to originate from luminal epithelial progenitors rather than from basal stem cells [17]Signaling pathways including Wnt, Notch, Hedgehog, p53, PI3K and HIF are involved in the self-renewal, proliferation and invasion of bCSCs [18-21]\",\n      \"title\": \"Risk Factors and Preventions of Breast Cancer.pdf\"\n    }\n  ]\n}",
  "ai_answer": "您好，您目前24岁，出现月经干净后一两天洗澡时乳头能挤出东西的情况，虽然之前挤过好像没有，但仍建议您尽快前往正规医院乳腺专科就诊。通过完善乳腺超声、钼靶等检查来明确乳头溢液的具体原因。从临床角度来说，非哺乳期的乳头溢液需要排除一些病理性因素。在等待就诊过程中，您要保持放松的心态，避免过度焦虑。目前处于可能的术前评估前期阶段，日常注意不要频繁刺激乳头，保持乳房局部清洁卫生。关于康复锻炼暂时还没有特定的针对性需求，但要留意后续检查结果来进一步规划。营养方面保持均衡饮食即可，心理上可通过和家人朋友沟通等方式缓解担忧情绪，及时就医是明确情况的关键。",
  "ref_answer": "部分女性在断奶后一年内可有乳头泌乳，且挤压后有乳汁样溢液一般以生理性溢液居多，但单孔溢液可能与乳腺导管内乳头状瘤有关，应到医院检查，明确原因。",
  "context_relevance": 0.47721365094184875,
  "faithfulness": 0.5012498497962952,
  "answer_relevance": 0.7863258719444275,
  "answer_correctness": 0.6396634578704834,
  "context_recall": 0.0,
  "rag_score_mean": 0.480890566110611
}